Anne Horgan

Anne Horgan is a Partner at Cambridge Innovation Capital, where Anne focuses on Life Sciences investments.

Anne brings over two decades of experience across drug discovery, technology transfer, business development, and equity financing in the Life Sciences sector.

Before joining Cambridge Innovation Capital, Anne was a Partner at Advent France Biotechnology (now AdBio Partners) and a Senior Associate at Sofinnova Partners. Anne's early career included roles as a Senior Medicinal Chemist at Cambridge Biotechnology Ltd and a Business Development Executive at Cancer Research Technology (now Cancer Research Horizons).

Anne holds a PhD in synthetic organic chemistry from the University of Bristol and completed postdoctoral research at Yale University. Anne is an inventor on eight patent families and has authored several peer-reviewed papers.

Currently, Anne manages CIC's investments in companies such as Complement Therapeutics, Microbiotica, and T-Therapeutics, alongside Start Codon portfolio companies. Anne is also an Industry and Enterprise Fellow at Clare Hall, University of Cambridge, and is committed to fostering an inclusive UK life sciences sector.

Bio is AI generated & may not be accurate.